A Very Long-acting Exatecan and Its Synergism with DNA Damage Response Inhibitors.
Cancer research communications(2023)
摘要
A circulating conjugate that slowly releases Exa is described. It is efficacious after a single dose and synergistic with ATR and PARP inhibitors.
更多查看译文
关键词
exatecan,dna damage response,inhibitors,long-acting
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要